| Literature DB >> 34017770 |
Neeraj Singla1, Rudresh Gowda1, Ritin Mohindra1, Vikas Suri1, Deba Prasad Dhibar1, Navneet Sharma1.
Abstract
AIM: The aim of this study is to elucidate the demographics, symptoms and outcome of sick persons visiting coronavirus (COVID) screening OPD of a tertiary institute in North India. STUDYEntities:
Keywords: COVID-19; clinical predictors; cough; critical condition; tachycardia; tachypnoea
Year: 2021 PMID: 34017770 PMCID: PMC8132783 DOI: 10.4103/jfmpc.jfmpc_1827_20
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Figure 1Flow chart depicting the study design and patient distribution
Baseline characteristics of patients screened in the flu screening centre
| Number | Total percentage | |
|---|---|---|
| Total number of patients | 1030 | |
| Demographics | ||
| Age | ||
| <20 years | 47 | 4.6 |
| 20-40 | 651 | 63.2 |
| 41-60 | 246 | 23.9 |
| >60 | 86 | 8.3 |
| Sex | ||
| Male | 676 | 65.6 |
| Female | 354 | 34.4 |
| History of risk of exposure | ||
| Resident of hotspot | 109 | 10.6 |
| History of visit to hotspot | 44 | 4.3 |
| History of contact with confirmed case | 286 | 27.8 |
| History of international travel | 68 | 6.6 |
| Healthcare worker | 204 | 19.8 |
| History of BCG vaccination | 1016 | 98.6 |
| Clinical presentations | ||
| Asymptomatic | 291 | 28.3 |
| Symptomatic | 738 | 71.7 |
| History of fever | 508 | 49.3 |
| Cough | 588 | 57.1 |
| Sore throat | 448 | 43.5 |
| Runny nose | 127 | 12.3 |
| Shortness of breath | 171 | 16.6 |
| Diarrhoea | 20 | 1.9 |
| Myalgia | 24 | 2.3 |
| Anosmia | 3 | 0.3 |
| Ageusia | 3 | 0.3 |
| Comorbidities | 88 | 8.5 |
| Diabetes mellitus | 35 | 3.4 |
| Hypertension | 36 | 3.5 |
| COPD | 5 | 0.5 |
| CKD | 29 | 2.8 |
| CLD | 4 | 0.4 |
| CAD | 18 | 1.7 |
| HIV | 4 | 0.4 |
| Malignancies | 7 | 0.7 |
| General condition (normal) | 1005 | 97.6 |
| General condition (critical) | 25 | 2.4 |
| Tachycardia | 130 | 12.6 |
| Low oxygen saturation | 136 | 13.2 |
| Temp. >100°F | 478 | 46.4 |
| Tachypnoea | 151 | 14.7 |
| COVID-19 suspected | 654 | 63.5 |
Figure 2Bar diagram showing age and gender distribution
Figure 3Patient distribution based on high-risk factors
Figure 4Symptomatic status of patients reporting to flu screening centre
Figure 5Various clinical manifestations in patients
Figure 6Prevalence of different comorbidities in patients
Figure 7General condition of patients reporting to flu screening centre
Figure 8Defining parameters in critical patients with influenza-like illness
Correlation between all the parameters and COVID-19
| Clinical presentation | COVID-19 negative | COVID-19 positive | |
|---|---|---|---|
| Asymptomatic | 269 (93.1%) | 20 (6.9%) | 0.002** |
| Fever | 494 (97.2%) | 14 (2.8%) | 0.063 |
| Running nose | 127 (100%) | 0 | 0.015 |
| Shortness of breath | 160 (93.6%) | 11 (6.4%) | 0.060 |
| Cough | 574 (97.6%) | 14 (2.4%) | 0.004** |
| Sore throat | 442 (98.7%) | 6 (1.3%) | <0.001** |
| Resident of hot spot | 94 (86.2%) | 25 (2.7%) | <0.001** |
| History of visit to hotspot area | 43 (997.7%) | 1 (2.3%) | 0.570 |
| History of international travel | 67 (98.5%) | 1 (1.5%) | 0.285 |
| Healthcare worker | 196 (96.1%) | 8 (3.9%) | 0.980 |
| History of contact with confirmed case | 260 (91.5%) | 24 (8.5%) | <0.001** |
| Comorbidity | 79 (89.8%) | 9 (10.2%) | 0.001** |
| Hypertension | 33 (91.7%) | 3 (8.3%) | 0.161 |
| Diabetes mellitus | 30 (85.7%) | 5 (14.3%) | 0.001** |
| Chronic liver disease | 4 (100%) | 0 | 0.687 |
| CAD | 18 (100%) | 0 | 0.389 |
| Chronic kidney disease | 25 (86.2%) | 4 (13.8%) | 0.005** |
| Oxygen saturation | 125 (91.9%) | 11 (8.1%) | 0.007** |
| Temperature | 463 (96.9%) | 15 (3.1%) | 0.244 |
| Tachypnoea | 140 (92.7%) | 11 (7.3%) | 0.020* |
| Critical condition | 19 (76%) | 6 (24%) | <0.001** |
| Tachycardia | 117 (90.0%) | 13 (10.0%) | <0.001** |
| COVID-19 suspect | 615 (94%) | 39 (6.0%) | <0.001** |
P<0.05; *significant. P<0.01; **highly significant
Multivariate logistic regression analysis of mortality risk factors for patients with COVID-19
| Patient's parameters | Odd's ratio | 95% Confidence interval for odd's ratio | |
|---|---|---|---|
| COVID-19 positive | 0.001** | 11.475 | 2.63-50.064 |
| Tachycardia | 0.020* | 6.715 | 1.34-33.524 |
| Shortness of breath | 0.013* | 17.52 | 1.83-167.74 |
P<0.05; *significant. P<0.01; **highly significant